These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Novo Nordisk’s Ozempic, Wegovy, and Rybelsus are all part of the same category of drugs called semaglutides, which originally were developed to treat type 2 diabetes—in part by helping people shed pounds better than any previous medication and therefore control their blood sugar. But it wasn’t until recently that their weight-loss feature propelled them to be among the most in-demand prescription medications. Still, the drugs aren’t without controversy over inappropriate use and side effects, including stomach and intestinal issues, that have prompted a warning from the FDA.
More Must-Reads from TIME
- L.A. Fires Show Reality of 1.5°C of Warming
- How Canada Fell Out of Love With Trudeau
- Trump Is Treating the Globe Like a Monopoly Board
- Bad Bunny On Heartbreak and New Album
- 10 Boundaries Therapists Want You to Set in the New Year
- The Motivational Trick That Makes You Exercise Harder
- Nicole Kidman Is a Pure Pleasure to Watch in Babygirl
- Column: Jimmy Carter’s Global Legacy Was Moral Clarity
